Wisdom Pharmaceuticals and East China Normal University jointly released the world's first ADC and nucleotide monomer drug intelligent manufacturing system.

On November 17th, the "Beyond Limits Intelligent Manufacturing" ADC and Nucleotide Monomer Drug Intelligent Manufacturing System Launch Conference was held in Zhangjiang, Shanghai. Rui Zhi Pharmaceutical, in collaboration with East China Normal University, officially launched the world's first intelligent manufacturing system for ADC and nucleotide monomer synthetic drugs. This innovative achievement is expected to promote the comprehensive upgrading of the pharmaceutical industry towards continuity, miniaturization, and intelligence, reshaping the overall paradigm of drug research and production. It marks China's achievement of independent controllability in the core technology and equipment field of biopharmaceuticals, injecting new energy into the sustainable development of China's innovative drug industry.